Selectivity and affinity

Predict and characterize the pharmacological profile

The ability to identify very early the selectivity of the compound for a target relative to its affinity for other targets ensures the precise biological activity of the compound. A low selectivity will then result in risk of side effects or adverse reactions to the effectiveness of the compound in its targeted therapeutic goal.

 

Through our in silico platform, the module MultiDIP ® Profiling provides a reliable and accurate needs assessment and early identifying the selectivity of a compound on its target, together with potential problems of undesirable activities and Side effects:

• Level 1: The screening targets to identify the problems of selectivity (go / no go);
• Level 2: Characterization of the selectivity and affinity with the target (go / no go, lead optimization).

 

 

If you would like to know more about our services, discuss custom assays, specific research, or get a quote, please, This e-mail address is being protected from spambots. You need JavaScript enabled to view it .